Status:
UNKNOWN
Ocular Surface Changes in Patients With Cystic Fibrosis
Lead Sponsor:
University of Bialystok
Conditions:
Eye Manifestations
Eligibility:
All Genders
3-25 years
Brief Summary
Cystic fibrosis(CF) is an inherited disease affecting children, adolescents and young adults with dysfunction of secretory glands.It is caused by mutations in the protein-coding gene which function as...
Detailed Description
The aim: To assess the role of chosen parameters of immunological response in the induction of ocular changes in cystic fibrosis patients, particularly chosen chemokine concentrations in the tear flui...
Eligibility Criteria
Inclusion
- male and female patients aged 3-25 with clinically definite diagnosis of cystic fibrosis
- all patients must give written consent for participation in the study at screening
Exclusion
- patients with a history of chronic disease of the immune system
- patients with the history of systemic diseases
- patients with the history chronic ocular diseases
- patients who have been treated with corticosteroids in the past 3 months prior to the screening visit
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00345280
Start Date
August 1 2006
End Date
September 1 2008
Last Update
June 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University
Bialystok, Poland, 15- 089